The historical rank and industry rank for Applied BioCode's FCF Margin % or its related term are showing as below:
TPE:6598'
s FCF Margin % Range Over the Past 10 Years
Min: -1581.81 Med: -60.56 Max: 31.7
Current: -49.55
During the past 13 years, the highest FCF Margin % of Applied BioCode was 31.70%. The lowest was -1581.81%. And the median was -60.56%.
TPE:6598's FCF Margin % is ranked worse than 78.9% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs TPE:6598: -49.55
Applied BioCode FCF Margin % Related Terms
Applied BioCode FCF Margin % Historical Data
* Premium members only.
The historical data trend for Applied BioCode's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6598 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Applied BioCode's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Applied BioCode FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Applied BioCode's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Applied BioCode (TPE:6598) has a FCF Margin % of -53.63% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Applied BioCode and its competitors. According to the industry distribution chart, Applied BioCode ranks #643 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 78.9%.
Is Applied BioCode's FCF Margin % too high?
Applied BioCode's current FCF Margin % is -53.63%. Based on the distribution chart, Applied BioCode ranks #643 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Applied BioCode ranks #643 out of 815 companies for FCF Margin %. This places Applied BioCode in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Applied BioCode and its competitors. Applied BioCode's current FCF Margin % is -53.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.33, compared to a current price of NT$22.90 — trading 1.8% below its estimated fair value. The current FCF Margin % is -53.63%. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current FCF Margin % is -53.63% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Applied BioCode (TPE:6598) Overvalued in 2026?
Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued.
The current stock price of NT$22.90 is trading 1.8% below its estimated GF Value™ of NT$23.33.
GuruFocus considers Applied BioCode to be Fairly Valued.
Key valuation signals for TPE:6598:
FCF Margin %: -53.63%
GF Value™: NT$23.33 vs. price of NT$22.90 (1.8% below fair value)
No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score
Get the complete analysis for TPE:6598
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6598 has been successfully added to your 
